Nationwide Launch of New Biomaterial: DyNoss®

MAITLAND, FLORIDA — June 14th, 2004 — Scient’x USA announces today the nationwide launch of their New Synthetic Cancellous Bone Void Filler: DyNoss®.

DyNoss® is FDA approved, and manufactured in the US from a proprietary combination of Hydroxyapatite (HA) and Beta-Tricalcium Phosphate (B-TCP). It provides the ideal environment for new bone formation due to its microcrystalline structure that closely mimics that of human bone.

Craig Corrance, President of Scient’x USA, suggests that “DyNoss® will have an extremely positive impact on the company’s 2004 sales objectives considering that the use of Biomaterials within the discipline of Spinal Surgery continues to increase rapidly. We are excited to branch into this new technological arena, particularly as biomaterials are forecasted to represent 30% of industry sales by 2012”

Mr. Corrance also noted that “In addition to the strong demand for our Dynamic Semi-Rigid Rod Technology, physicians’ acceptance of our expanded product portfolio continued to grow in the first quarter of 2004, especially with the launch of Scient’x USA’s PEEK technology. DyNoss® reinforces our aggressive diversification strategy within the Spinal Arena.”

For more information on the Ostetic product line and on how to purchase Ostetic products, please visit the company's web site: http://www.ostetic.com.

About Berkeley Advanced Biomaterials:
Formed in 1996 to develop biomaterials for orthopedic applications, BAB introduced its Ostetic line of bone filler materials in 2002. The company continues to work with academic and corporate laboratories to develop novel biomaterials. BAB is a privately held company with headquarters in Berkeley, California. For more information, visit the company's website: http://www.ostetic.com.